Advertisement IMGM Laboratories deploys Fluidigm Access Array System - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

IMGM Laboratories deploys Fluidigm Access Array System

IMGM Laboratories has deployed the Fluidigm Access Array System into its amplicon-based targeted re-sequencing workflow using the Roche 454 NGS sequencing technology to use in the development and validation of targeted re-sequencing applications services.

The Fluidigm Access Array System is an automated sample preparation system for next-generation sequencing that provides parallel amplification of 48 unique samples, in effect preparing 48 sequencing libraries, in just a few hours.

Every reaction combines both an amplicon tagging and a barcoding (identification) step that enables all 48 amplicons to be multiplexed in a sequencing run.

The Access Array technology simplifies the labor-intensive up-front preparation, minimizes preparation error, and allows for the maximum utility of next generation sequencers.

Fluidigm develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries.